Harmony Biosciences Holdings, Inc.
HRMY
$28.46
$0.521.86%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 12.91% | -18.66% | -42.57% | -27.32% | -28.99% |
| Total Depreciation and Amortization | -1.01% | -0.14% | 0.61% | 0.70% | 4.17% |
| Total Amortization of Deferred Charges | -69.22% | -71.49% | 6.55% | 22.26% | 36.74% |
| Total Other Non-Cash Items | 96.90% | 220.49% | 206.22% | 154.40% | 149.82% |
| Change in Net Operating Assets | -120.90% | 129.97% | 3,295.19% | 246.92% | 953.26% |
| Cash from Operations | 0.20% | 30.42% | 32.21% | 31.48% | 51.86% |
| Capital Expenditure | -269.55% | -264.39% | -155.67% | -149.61% | -81.40% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 10.54% | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -263.12% | 55.17% | 69.37% | 86.90% | 93.53% |
| Cash from Investing | -45.32% | -68.26% | -10.14% | 50.92% | 67.26% |
| Total Debt Issued | -- | -100.00% | -- | -- | -- |
| Total Debt Repaid | 92.55% | 92.42% | -10,287.50% | -10,125.00% | -9,962.50% |
| Issuance of Common Stock | 28.61% | -56.29% | -88.73% | -88.39% | -42.82% |
| Repurchase of Common Stock | 97.52% | 0.49% | -19,407.59% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | -- | -- | -- |
| Cash from Financing | 89.58% | -25.13% | -1,587.55% | -1,369.82% | -1,642.93% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 109.72% | 0.04% | -100.12% | -29.82% | 611.30% |